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Hybrid nano-Gdf3 contrast media 
allows pre-clinical in vivo element-
specific K-edge imaging and 
quantification
niki Halttunen1, frederic Lerouge1, frederic chaput1, Marc Vandamme2, Szilvia Karpati1, 
Salim Si-Mohamed  3,4, Monica Sigovan3, Loic Boussel3, emmanuel chereul  2, 
philippe Douek3,4 & Stephane parola1
Computed tomography (CT) is a widely used imaging modality. Among the recent technical 
improvements to increase the range of detection for optimized diagnostic, new devices such as dual 
energy CT allow elemental discrimination but still remain limited to two energies. Spectral photon-
counting CT (SPCCT) is an emerging X-ray imaging technology with a completely new multiple 
energy detection and high spatial resolution (200 μm). This unique technique allows detection and 
quantification of a given element thanks to an element-specific increase in X-ray absorption for an 
energy (K-band) depending on its atomic number. The main contrast media used hitherto are iodine-
based compounds but the K-edge of iodine (33.2 keV) is out of the range of detection. Therefore, it is 
crucial to develop contrast media suitable for this advanced technology. Gadolinium, well known and 
used element for MRI, possess a K-edge (50.2 keV) well suited for the SPCCT modality. The use of nano-
objects instead of molecular entities is pushed by the necessity of high local concentration. In this work, 
nano-Gdf3 is validated on a clinical based prototype, to be used as efficient in vivo contrast media. 
Beside an extremely high stability, it presents long lasting time in the blood pool allowing perfusion 
imaging of small animals, without apparent toxicity.
Since its introduction over 40 years ago1,2, CT has become one of the most used imaging modalities with MRI 
for clinical purposes in hospitals, especially in the emergency room. CT has known many evolutions most of 
them aiming to improve the image resolution, the scanning speed or to lower the radiation dose received by 
the patient. These developments have led to the very recent dual energy CT currently available commercially. 
However, improvements to the CT technology are still ongoing and new improvements are being developed at 
the present day, among the most recent ones is the K-edge imaging. After the concept was initially proven at syn-
chrotron facilities3, the system and the reconstruction algorithms have been developed. Today the technology is 
matured enough to build prototypes under the form of the spectral photon-counting CT4–8.
Spectral photon-counting CT (SPCCT) is an emerging X-ray imaging technology with a completely new type 
of detection chain which pairs high count-rate capabilities to multiple energy discrimination and high spatial 
resolution (200 μm)9–14. This energy discrimination allows, in comparison with standard CT technology, a better 
sampling of the spectral information from the transmitted spectrum. It gives additional physical information 
produced during matter interaction, including photo-electric, Compton and K-edge effect. The K-edge can be 
described as an element-specific imaging corresponding to the measurement of the increase of the mass atten-
uation coefficient, at an energy corresponding to the K-band of the element12. Furthermore, not only K-edge 
imaging allows to detect a specific element, it also enables to quantify it. It is thus possible to accurately locate 
and dose the contrast media within the tissues. Since the energy range of the X-ray tube emission in the SPCCT 
is 30 keV to 120 keV, only elements with a K-edge value between these values can be detected13,15–18. The main 
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contrast agents used in CT scan today are iodine-based compounds; however, due to its low K-edge (33.2 keV), 
iodine is not suitable for K-edge imaging because of the photon starvation at that energy. Therefore, it is necessary 
to develop new systems suitable for this technology.
Gadolinium is an element with a k-edge of 50.2 keV, which is within the detection range of the X-ray tube 
emission. This element is already well known and used for its magnetic properties as contrast media for MRI 
under its Gd3+ cage-complex form (DOTAREM, GADOVIST) in clinics or nanoparticles in research devel-
opments19,20. Despite the current use of molecular systems on human patients, drawbacks have been recently 
pointed out with the leaking of gadolinium ions that can accumulate in the brain21. Such molecules also show 
very short lifetime in the body (fast renal clearance) associated with a relatively small amount of gadolinium in 
mass. In order to be used as contrast agents with SPCCT, Gadolinium based systems must (i) be highly stable, (ii) 
contain a high amount of element for a better imaging, and (iii) show a blood half-life long enough to allow perfu-
sion imaging. Recent development reports the use of molecularly based contrast media22. However as previously 
pointed out, the requirements on such technology, in particular the local concentration and the stability towards 
Gd3+ release, led us to investigate the potential of hybrid nanoparticles with high gadolinium loading and stable 
inorganic core.
We discuss herein the preparation and in vivo evaluation of ultra-small GdF3 nanocrystals as stable efficient 
contrast media for angiography with SPCCT clinical prototype suitable for preclinical studies, with a biodistri-
bution study on mice and K-edge imaging on rats. These nanoparticles present two main advantages compared 
to the organometallic gadolinium complexes. First, they feature a very high stability with no possible gadolinium 
leakage23,24. Secondly, these nanoparticles show a high payload of gadolinium ions (from 104 to 106 Gd3+ depend-
ing on the exact particle diameter, between 9 nm and 25 nm). These systems provide thus a very high local density 
of active ions, making them efficient probes for various imaging modalities.
Results
Particle synthesis and characterization. The GdF3 nanoparticles were synthetized following a previ-
ously described process, with few modifications23,24. Briefly, a solution of gadolinium chloride in a mixture of 
ethylene glycol and 2-pyrolidinone was reacted under solvothermal conditions with a mixture of hydrofluoric 
acid (HF) in 2-pyrrolidinone. The obtained charge transfer complex acts both as a precursor of fluoride ions and a 
stabilizing agent preventing further growth of the nanoparticles. After several purification steps GdF3 nanoparti-
cles gave a perfectly stable suspension in water. Transmission electron microscopy (TEM) and dynamic light scat-
tering (DLS) showed that the nanocrystals exhibited an average size of about 10 nm with a low polydispersity and 
a hydrodynamic diameter centred at 14 nm. TEM images of the nanoparticles confirmed the crystalline (Fig. 1). 
The diffraction pattern of GdF3 (Fig. 1) was in good agreement with the TEM pictures revealing the presence of 
highly crystalline nanostructures with an orthorhombic phase.
Despite the fact that GdF3 nanoparticles showed great stability in water, surface modification needed to be 
considered for biological applications, specially to ensure a long remaining time in blood after in vivo injection. 
The surface of the GdF3 nanocrystals was thus functionalized using phosphonate-based Polyethyleneglycol lig-
ands leading to both biocompatible and stable hybrid nanoparticles. Usually, anchoring groups used for surface 
functionalization of similar systems are carboxylic acids or their derivatives such as carboxylate salts, esters or 
amides. However, phosphonates groups were more suitable due to their strong efficiency to bind with the lan-
thanide at the surface of the particles. Effective surface modification of the nanoparticles was first observed by 
DLS, which showed an increase in the hydrodynamic diameter from 14 up to 18 nm. Fourier transform Infrared 
(FT-IR) analysis were also in agreement with the presence of ligands with specific signals of the phosphonate 
groups in the 950–1100 cm−1 range corresponding to the P-OH (950 cm−1) and P-O (1105 cm−1) vibrations and 
signals corresponding to the C-H stretching mode at 2870 cm−1.
Radioopacity calibration. To determine injection volume and product concentration for the in vivo appli-
cation, a complete toxicology study is needed with dose escalation. In this first approach, the determination of the 
radio-opacity of the product was evaluated by CT and µCT imaging in tubes. To this end, the ability of the nan-
oparticules to absorb X-Ray was evaluated on suspension of GdF3 in NaCl 0.9% with various concentrations in 
Figure 1. Transmission Electron Microscopy of GdF3 nanoparticles (left); High resolution of the crystalline 
nanoparticles (middle) and powder X-Ray Diffraction pattern (right).
3Scientific RepoRtS |         (2019) 9:12090  | https://doi.org/10.1038/s41598-019-48641-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
Gd3+ (Fig. 2). A linear behavior was observed in both cases on a wide range of concentrations from 0.001 mg/mL 
up to 47 mg/mL (ie 0.01 mM up to 300 mM) with a constant increase of HU units (R² = 0.995, slope 4.88). 
Interesting results were observed in the lower range of concentrations. Considering HU value in muscle and soft 
tissue, a minimum value of 100 HU was needed in order to have a sufficient contrast, therefore concentrations of 
at least 2.35 mg/mL were necessary in order to observe the particles in biological tissues. This result proved the 
efficiency of the nanoparticles to act as contrast agents with CT imaging.
In vivo biodistribution. In vivo studies were conducted on mice in order to evaluate the behaviour of the 
nanoparticles in vivo and confirm their efficacy as blood pool contrast media. Before injection, the particles were 
dispersed in physiological serum (NaCl 0.1 M in water) with various concentrations of gadolinium atoms, ranging 
from 20 mM to 300 mM. Once the particles were in solution, the mixture was stable for several months with no 
noticeable change.
Biodistribution was performed in vivo by monitoring the heart, liver and kidneys on a series of 4 animals with 
5 different concentrations (20 mM, 40 mM, 80 mM, 150 mM and 300 mM) of Gadolinium, few minutes and up 
to 24 hours after injection (Figs 3 and 4). No animal mortality was observed during the study. Intense signal was 
noticeable in the heart of the animals after injection with a maximum at 30 min. Whatever the gadolinium con-
centration was, the strong contrast faded slowly after more than two hours, proving the long remaining time of 
the nanoparticles in the blood pool. These observations were confirmed in the case of the liver and a slow increase 
of the contrast was measured with a maximum corresponding to 24 hours after the injection. Such result demon-
strated the slow uptake of the particles by the reticuloendothelial system and confirmed their high stability in the 
blood. These observations were completed with a monitoring of the kidney, where no contrast ie no localization of 
the particles was observed in that area. This also confirmed the fact that the majority of the particles were located 
in the liver after one day of experiment, without renal clearance.
The hybrid nano-GdF3 contrast media is thus an efficient tool for CT imaging, providing great contrast with a 
long-lasting period of time in the blood circulation. It can further be used as efficient perfusion imaging contrast 
media.
In vivo K-edge imaging. Evaluation of the k-edge imaging with the hybrid nano-GdF3 contrast media was 
performed using SPCCT prototype (Philips Healthcare, Haifa, Israel), first in vitro on phantom tubes with a range 
of gadolinium concentrations (2–20 mg/mL). Comparison with HU image was also conducted on the same appa-
ratus (Fig. 5). K-edge observations only showed signals due to the element gadolinium in the phantom and the 
tube holder did not appear in the image. This result showed the specificity of the imaging technology for one ele-
ment. In the case of HU observations corresponding to a classical scanner CT, both tubes and sample holder were 
imaged. Results were in good agreement with previous measurement and the limit of detection was observed for 
a concentration of 2 mg/mL of gadolinium.
Since this modality allows the quantification of a given element, a correlation between expected and measured 
concentrations was performed to assess and validate the accuracy of the method for gadolinium. A series of nan-
oparticles suspension in water at various concentration of gadolinium was first evaluated with ICP. The solutions 
were then analyzed by k-edge and the results were compared (Fig. 6).
The obtained curve shows a good correlation between the concentration obtained from ICP and the measured 
ones with the spectral scanner technology in the lower range (0–4 mg/mL). A slight deviation is observed above 
4 mg/mL and the measured concentration is always below the expected result but still in the error margin.
Evaluation of GdF3 contrast media was performed after systemic injection in vivo on healthy rat, for perfusion 
imaging of the abdomen. Acquisitions were performed before and after the injection of 2.5 mL of 1 M GdF3 (gad-
olinium amount: 10 mg/g of animal) by focusing on the arteriovenous system (Fig. 7).
First, when imaging was performed through conventional CT technology, a strong HU signal was visible 
(grey) allowing the visualization of vascularization (small vessels and arteries). The observation of the blood net-
work agreed with the long persistence of the GdF3 in the blood stream. K-edge imaging (in yellow) provided a spe-
cific image of the contrast media in the animal vasculature. The signal represented specifically the agent of interest 
Figure 2. Calibration of GdF3, radio opacity measurements (HU) as a function of Gadolinium concentration. 
The right plot represents a zoom section of the 0–12 mg/mL range issued from the left plot.
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in the arteries and the surrounding vessels, although the image was noisy such as it has been related in a previ-
ously published paper13 where the authors found a noise value within the gadolinium images around 0.5 mg/mL. 
It was thus possible to distinguish the profile of the blood vessel thanks to the Gadolinium element of the particles 
and no bones (spine or hips) were observed. Merging of both imaging modalities allowed the observation of the 
abdomen vascularization of the animal and the localization of the particles in the blood stream. Such results are 
very encouraging for further studies in the frame of vascularization-associated pathologies such as ischemia or 
cancer angiogenesis.
Figure 3. In vivo monitoring and CT images of the hybrid nano-GdF3 particles in the Heart (top left), the liver 
(top right), the kidney (bottom). CT images at T = 0 and 1 minute are shown in Fig. 4.
Figure 4. CT images at T = 0 and 1 minute.
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Figure 5. (Left) SPCCT gadolinium K-edge image of a phantom consisting of GdF3 suspensions of various 
gadolinium concentrations from 2 mg/mL up to 20 mg/mL (12 mM to 120 mM respectively) (Right) Same 
phantom observed with SPCCT conventional image.
Figure 6. Correlation between measured concentration of gadolinium with K-edge and expected 
concentrations of the corresponding solutions determined by ICP.
Figure 7. SPCCT conventional HU image (A) SPCCT gadolinium K-edge image (B) and overlay between 
SPCCT conventional HU and Gd K-edge images (C) of abdomen of rat after GdF3 injection (5 min). Both 
images are reconstructed on an isotropic voxel grid at 250 µm * 250 µm * 250 µm.
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In vivo quantification. With conventional CT imaging, the characterization of tissue or amount of contrast 
media relies only on the signal attenuation. This lack of specific and quantitative evaluation of contrast agent dis-
tribution has been overcome using the SPCCT k-edge modality. The specific imaging of gadolinium element in 
the new probe became possible and the quantification was performed using ROI manually delineated in aorta 
(Fig. 8).
Thus, a gadolinium concentration of 17.3 mg/mL was directly quantified whereas when using a conventional 
CT, a real concentration determination was not possible. Since the modality is directly related to the atomic num-
ber of the element and given the fact that Gadolinium’s is much higher than surrounding matrix such as water or 
plasma, the correlation between ICP and measured concentration (Fig. 6) applies.
This result shows the potential of SPCCT to determine a gadolinium concentration in a given volume. Using 
this technology and the scanning rapidity, it is possible to track the bolus injection of contrast media and to quan-
tify tissue perfusion such as in the case of myocardial infarction.
conclusions
Spectral photon-counting CT (SPCCT) imaging shows today an extremely high potentiality for medical diag-
nostic and requires simultaneous combination with efficient contrast media with compatible K-edge and high 
local element density. Nano-GdF3 appears to be a good candidate for use as contrast media in SPCCT. It presents 
a long blood half-life allowing in vivo injections and imaging of small and medium animals models. It shows 
extremely high stability with strong potential in term of non-toxicity. Not only imaging on the contrast media 
can be performed in vivo, but element specific quantification is possible in region of interest and as performed 
during imaging acquisition. The results on the hybrid nano-GdF3 as long-lasting blood pool agent are extremely 
encouraging, allowing future perfusion imaging at preclinical stage.
Methods
Animal experiments. All experiments were performed in accordance with relevant guidelines and reg-
ulations. The animal experiments were carried out according to the principles of laboratory animal care and 
European legislation (Council Directive No. 2010/63/UE on the protection of animals used for scientific pur-
pose). This protocol was submitted to our local ethical committee (C2EA-18 VETAGRO-SUP) and to the French 
authorities and received a favorable opinion on 09/11/2014 (Project No. 1427_v3).
Female Balb/cJRj mice and male Wistar Rats (RjHan:WI) were purchased from JANVIER Laboratories (7 
weeks old and 6 weeks old respectively) weighing about 25–30 g for the mice and 180–220 g for the rats were used 
for the in vivo studies. Mice and rats were provided with standard mouse food and water ad libitum and main-
tained under conventional housing conditions in a temperature-controlled room with 12-hour dark–light cycle.
For pharmacokinetics and biodistribution studies: mice were divided into five groups of treatment which 
received different nanoparticles concentration: 20 mM, 40 mM, 80 mM, 150 mM and 300 mM.
Imaging protocol. CT acquisitions were performed using two CT systems. The first one, for biodistribution 
study, is a standard CT (General Electric BrightSpeed 16 Elite, GE, France) using 120 kV, 150 mA, a field-of-view 
(FOV) of 50 cm and a spatial resolution of 310 µm at consecutive time points (T = 0, 1, 30, 120 minutes and 
24 hours).
The second one, for Gd3+ K-edge imaging, is a spectral photon-counting prototype CT system (SPCCT, 
Philips Healthcare, Haifa, Israel). It is a modified base clinical system with a conventional scintillator detector 
replaced by a photon-counting detector of smaller coverage. It is a equipped with a conventional X-ray tube, 
and a conventional small bowtie filter, delivering a radiation dose similar to a standard CT. For information, a 
CTDIweighted at 0.74 mGy has been measured for an axial scan over 360 degrees at 100 mA tube current and 
120 kVp tube voltage. The scan FOV was 168 mm in-plane, with a z-coverage of 2.5 mm in the scanner iso-center. 
Figure 8. Delimited box (in red) for Gd3+ quantification in the aorta.
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Axial and helical scans over 360 degrees were performed at 100 mA tube current and 120 kVp tube voltage with a 
scanner rotation time of 1 s and 2400 projections per rotation.
Images of gadolinium were generated via the K-edge technique taking benefit from the energy resolving 
detectors. This technique is based on the detection of the K-edge effect of a material defined as the binding energy 
of its K-shell electron. To allow this, the SPCCT is based on hybrid photon counting detectors, ChromAIX2 
application-specific integrated circuits combined with cadmium zinc telluride (CZT) as sensor material, and 
operates in single photon-counting mode with energy discrimination25. The photon counting detectors allowed 
up to five consecutive energy bins between 30 and 120 keV. 5 thresholds were adjusted in order to allow photon 
energy–based discrimination of the gadolinium. 2 thresholds just below and above their K-edges, at 50.2 keV, are 
needed such as demonstrated in previous papers26–28. One additional energy threshold served as a noise threshold 
and was set to 30 keV. Hence, the energy thresholds were set at 30, 51, 64, 72, 85 keV for the gadolinium study.
For each pixel, a maximum likelihood estimator was used to derive an equivalent water-thickness per pixel 
from the photon counts in the five energy bins. Sinograms were individually reconstructed with a reconstruction 
algorithm on a 0.25 × 0.25 × 0.25 mm3 voxel grid. Conventional images from the SPCCT were reconstructed from 
the water-thickness equivalent sinograms using a filtered back-projection algorithm. Gadolinium images were 
reconstructed from the five multi-energy sinograms after a discrimination process between 3 materials-based 
in the purpose to provide a three-material water-iodine-gadolinium basis. This process is based on a forward 
projection model (per detector) and maximum likelihood to determine the energy-dependant attenuation of the 
gadolinium28.
Regions of interest were manually drawn using a dedicated Software (Avizo, ThermoFischer) within the heart, 
liver and kidney (renal cortex) for quantification of the attenuation values in Hounsfield units on the SPCCT 
conventional HU images, and the concentrations in mg/ml on the SPCCT K-edge images.
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